Literature DB >> 2882541

Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390.

A Vaccheri, R Dall'Olio, O Gandolfi, P Roncada, N Montanaro.   

Abstract

Rats were treated for 21 days with the selective D-1 blocker SCH 23390 (0.1 mg/kg SC). Threshold doses of apomorphine for hypermotility (0.15 mg/kg SC) and for stereotyped response (0.25 mg/kg SC) were given 7, 21, 35, and 77 days after discontinuation of the chronic treatment. The rats always showed enhanced stereotyped response to the higher dose of apomorphine but never any change in their motility response to the lower dose of dopamine agonist. This finding may represent a behavioral correlate of the reported supersensitivity of D-1 receptors induced by SCH 23390.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2882541     DOI： 10.1007/bf00518199

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


  13 in total

1.  [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.

Authors:  M L Porceddu; E Ongini; G Biggio
Journal:  Eur J Pharmacol       Date:  1985-12-03       Impact factor: 4.432

2.  On the mode of action of apomorphine.

Authors:  B Costall; R J Naylor
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

3.  Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390.

Authors:  I Creese; A Chen
Journal:  Eur J Pharmacol       Date:  1985-02-12       Impact factor: 4.432

4.  Distinct effects of two stresses on the behavioral response to apomorphine.

Authors:  J G Csernansky; C A Csernansky; L E Hollister
Journal:  Life Sci       Date:  1984-10-01       Impact factor: 5.037

5.  Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.

Authors:  S Boyce; E Kelly; A Davis; S Fleminger; P Jenner; C D Marsden
Journal:  Biochem Pharmacol       Date:  1985-05-15       Impact factor: 5.858

7.  Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics.

Authors:  A V Christensen; J Arnt; J Hyttel; J J Larsen; O Svendsen
Journal:  Life Sci       Date:  1984-04-16       Impact factor: 5.037

8.  Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.

Authors:  N Montanaro; R Dall'Olio; O Gandolfi; A Vaccheri
Journal:  Eur J Pharmacol       Date:  1982-06-16       Impact factor: 4.432

9.  Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

Authors:  M T Pugh; K M O'Boyle; A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval.

Authors:  R Castro; P Abreu; C H Calzadilla; M Rodriguez
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
View more
  6 in total

1.  Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats.

Authors:  R Dall'Olio; O Gandolfi; A Vaccheri; P Roncada; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 2.  Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.

Authors:  G B Baker; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

Review 3.  Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.

Authors:  A R Braun; M Laruelle; M M Mouradian
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists.

Authors:  A J Stoessl; C T Dourish; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 5.  Controversies in translational research: drug self-administration.

Authors:  Margaret Haney; Roger Spealman
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

6.  Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats.

Authors:  Morgane Thomsen; Anders Fink-Jensen; David P D Woldbye; Gitta Wörtwein; Thomas N Sager; Rene Holm; Lauren M Pepe; S Barak Caine
Journal:  Psychopharmacology (Berl)       Date:  2008-07-09       Impact factor: 4.530
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.